Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001444

Drug Information
SynonymsCHEBI:747206; LS-173202; AC1L33UC; S1547; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; CHEMBL1164729; 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid; CID134018; 111GE013; MolPort-005-940-740; AC-425; 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid; Febuxostat; TEI; Febuxostat (JAN/USAN/INN); Tei-6720; CHEBI:45943; C16H16N2O3S; D01206; Tei 6720; UNII-101V0R1N2E; DB03786; TMX 67; 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-; 144060-53-7; Uloric; 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID; Febuxostat [USAN]; TMX-67, Adenuric, Uloric, Febuxostat; FT-0081351; S1547_Selleck; 5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-; TMX-67; Adenuric
Trade NameUloric
IndicationHyperuricaemia in patients with gout
[ICD9: 274, 790.6   ICD10: E79.0, M10]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O    
CAS NumberCAS 144060-53-7
PubChem Compound IDCID 134018.
PubChem Substance IDSID 710267.
SuperDrug ATC IDM04AA03
TargetXanthine oxidaseInhibitor[2][1]
Ref 1Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. To Reference
Ref 2Takeda. Product Development Pipeline. July 31 2009. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543